A Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle OA
Primary Purpose
Ankle Osteoarthritis
Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
PRP
Sponsored by

About this trial
This is an interventional treatment trial for Ankle Osteoarthritis focused on measuring Ankle joint, Osteoarthritis, Platelet rich plasma
Eligibility Criteria
Inclusion Criteria:
- Age of at least twenty years
- Ankle pain lasted for at least 6 months, despite conservative treatment or inability to tolerate the side effects of medications
- Ankle radiographs taken within 6 months (reviewed by the senior author) were equivalent to grade 1-4 osteoarthritis by the Kellgren Lawrence grading system
- Average ankle pain of > 3cm on a 10-cm visual analog scale (VAS)
- Radiological evidence of bilateral ankle osteoarthritis was accepted if VAS pain in the contralateral ankle was < 3 cm
- Normal activity level, not bedridden or confined to a wheelchair, able to walk 30 meters without the aid of a walker, crutches or cane
- No use of physical therapy or changes in shoes or orthotic devices during the study
Exclusion Criteria:
- Pregnancy or lactation in women
- Lower leg trauma in a location other than within the ankle
- Previous surgery involving the spine, hip or knee
- The presence of an active infection of the ankle
- Surgery involving the affected ankle within the previous 12 months
- Intraarticular steroid or hyaluronate injection in the ankle within the previous 6 months
- Treatment with anticoagulants or immunosuppressives
- History of rheumatoid arthritis, gout, or other inflammatory arthropathy
- The presence of visual or vestibular impairments
- Poor health status (such as a neoplasm, diabetes mellitus, or paresis) that would interfere with the assessments
Sites / Locations
- Department of Physical Medicine and Rehabilitation, Veterans General Hospital Kaohsiung
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
PRP injection
Arm Description
Patients with symptomatic ankle OA for at least 6 months were recruited. Patients received a single injection of 3-ml of PRP into symptomatic ankles.
Outcomes
Primary Outcome Measures
visual analog scale (VAS) of ankle pain
The patient rated the average severity of ankle pain on ankle movement over the previous week on a 10-cm VAS (0=no pain to 10=worst possible pain)
Secondary Outcome Measures
The Ankle Osteoarthritis Scale (AOS) score
AOS score is a validated patient-rated outcome measure that contains a nine-item pain subscale and a nine-item disability subscale. Using the AOS, a score of 0 represent no pain or disability and 10 represent worst pain or disability imaginable
The American Orthopedic Foot and Ankle Society (AOFAS) ankle/hindfoot score
a 100-point scale that devotes 40 points to pain, 50 points to function and 10 points to alignment. The maximum score of 100 points denotes no pain and normal function and alignment
The single-leg stance (SLS) test
SLS test involved raising the unaffected foot, without touching it to the affected lower extremity, and maintaining balance for as long as possible. Each participant performed three trials, and the best result was recorded
use of analgesic medication
The patient recorded the use of analgesic medication during the study period on a diary card.
global satisfaction
The patients rated his or her level of global satisfaction relative to the state before the treatment, using a 100 mm VAS (0= completely dissatisfied, 100=completely satisfied)
safety of PRP for ankle
The safety of the injection was monitored by recording the occurrence of systemic and local adverse events on a diary card
Full Information
NCT ID
NCT04022928
First Posted
July 11, 2019
Last Updated
July 17, 2019
Sponsor
Kaohsiung Veterans General Hospital.
1. Study Identification
Unique Protocol Identification Number
NCT04022928
Brief Title
A Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle OA
Official Title
Efficacy and Safety of a Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle Osteoarthritis-a Prospective Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
July 1, 2018 (Actual)
Primary Completion Date
November 30, 2018 (Actual)
Study Completion Date
May 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kaohsiung Veterans General Hospital.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Platelet-rich plasma (PRP) has been reported to be an effective treatment for knee osteoarthritis (OA). The application in ankle OA has rarely been investigated. The aim was to evaluate the efficacy and safety of a single intraarticular injection of PRP for the treatment of patients with ankle OA.
Detailed Description
Methods: In a prospective study, patients with symptomatic ankle OA for at least 6 months were recruited. Patients received a single injection of 3-ml of PRP into symptomatic ankles. The primary outcome was the change from baseline in the visual analog scale (VAS) pain score (0-10cm) at 6 months. Secondary outcomes included the Ankle Osteoarthritis Scale (AOS) score, American Orthopedic Foot and Ankle Society (AOFAS) ankle/hindfoot score, single leg stance test (SLS), use of rescue analgesics and patient satisfaction. Adverse events were recorded during the study.
Patients were followed at 1, 3 and 6 months postinjection .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ankle Osteoarthritis
Keywords
Ankle joint, Osteoarthritis, Platelet rich plasma
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
patients with symptomatic ankle OA for at least 6 months were recruited. Patients received a single injection of 3-ml of PRP into symptomatic ankles.
Masking
None (Open Label)
Allocation
N/A
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PRP injection
Arm Type
Experimental
Arm Description
Patients with symptomatic ankle OA for at least 6 months were recruited. Patients received a single injection of 3-ml of PRP into symptomatic ankles.
Intervention Type
Other
Intervention Name(s)
PRP
Intervention Description
, For PRP preparation, specialized platelet concentrate separator containing acid citrate dextrose as anticoagulant and a specific separator gel that harvest PR, preventing contamination of red blood cells and leukocytes were used.
Primary Outcome Measure Information:
Title
visual analog scale (VAS) of ankle pain
Description
The patient rated the average severity of ankle pain on ankle movement over the previous week on a 10-cm VAS (0=no pain to 10=worst possible pain)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
The Ankle Osteoarthritis Scale (AOS) score
Description
AOS score is a validated patient-rated outcome measure that contains a nine-item pain subscale and a nine-item disability subscale. Using the AOS, a score of 0 represent no pain or disability and 10 represent worst pain or disability imaginable
Time Frame
6 months
Title
The American Orthopedic Foot and Ankle Society (AOFAS) ankle/hindfoot score
Description
a 100-point scale that devotes 40 points to pain, 50 points to function and 10 points to alignment. The maximum score of 100 points denotes no pain and normal function and alignment
Time Frame
6 months
Title
The single-leg stance (SLS) test
Description
SLS test involved raising the unaffected foot, without touching it to the affected lower extremity, and maintaining balance for as long as possible. Each participant performed three trials, and the best result was recorded
Time Frame
6 months
Title
use of analgesic medication
Description
The patient recorded the use of analgesic medication during the study period on a diary card.
Time Frame
through study completion, an average of 6 months
Title
global satisfaction
Description
The patients rated his or her level of global satisfaction relative to the state before the treatment, using a 100 mm VAS (0= completely dissatisfied, 100=completely satisfied)
Time Frame
6 months
Title
safety of PRP for ankle
Description
The safety of the injection was monitored by recording the occurrence of systemic and local adverse events on a diary card
Time Frame
through study completion, an average of 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age of at least twenty years
Ankle pain lasted for at least 6 months, despite conservative treatment or inability to tolerate the side effects of medications
Ankle radiographs taken within 6 months (reviewed by the senior author) were equivalent to grade 1-4 osteoarthritis by the Kellgren Lawrence grading system
Average ankle pain of > 3cm on a 10-cm visual analog scale (VAS)
Radiological evidence of bilateral ankle osteoarthritis was accepted if VAS pain in the contralateral ankle was < 3 cm
Normal activity level, not bedridden or confined to a wheelchair, able to walk 30 meters without the aid of a walker, crutches or cane
No use of physical therapy or changes in shoes or orthotic devices during the study
Exclusion Criteria:
Pregnancy or lactation in women
Lower leg trauma in a location other than within the ankle
Previous surgery involving the spine, hip or knee
The presence of an active infection of the ankle
Surgery involving the affected ankle within the previous 12 months
Intraarticular steroid or hyaluronate injection in the ankle within the previous 6 months
Treatment with anticoagulants or immunosuppressives
History of rheumatoid arthritis, gout, or other inflammatory arthropathy
The presence of visual or vestibular impairments
Poor health status (such as a neoplasm, diabetes mellitus, or paresis) that would interfere with the assessments
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shu Fen Sun, MD
Organizational Affiliation
Kaohsiung Veterans General Hospital, Taiwan
Official's Role
Study Director
Facility Information:
Facility Name
Department of Physical Medicine and Rehabilitation, Veterans General Hospital Kaohsiung
City
Kaohsiung
ZIP/Postal Code
813
Country
Taiwan
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle OA
We'll reach out to this number within 24 hrs